You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tyrosine Kinase

Showing 1 - 25 of 3,912
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase

Recruiting
  • Liver Transplant
  • PVHA or TACE
  • Shanghai, Shanghai, China
    The value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

Recruiting
  • Liver Neoplasms
  • Tislelizumab plus tyrosine kinase inhibitor
  • Beijing, Beijing, China
    302 Hospital
Sep 22, 2023

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Breast Cancer Trial in Guangzhou (Take probiotics)

Recruiting
  • Breast Cancer
  • Take probiotics
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)

Completed
  • Gastrointestinal Stromal Tumors (GISTs)
  • Imatinib Mesylate
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 28, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tolebrutinib 60mg,

Active, not recruiting
  • Multiple Sclerosis
  • tolebrutinib 60mg
  • tolebrutinib 120mg
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

    Active, not recruiting
    • Patients Diagnosed as Chronic Meyloid Leukemia
    • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
    • Assiut, Egypt
      Assiut University Hospital
    Feb 19, 2022

    Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

    Not yet recruiting
    • Tyrosine Kinase Inhibitor
    • +2 more
      • Taipei, Taiwan
        National Taiwan University Hospital
      Feb 17, 2022

      Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

      Recruiting
      • Atrial Fibrillation
      • +4 more
      • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
      • New Hyde Park, New York
        Northwell (Northshore University/Long Island Jewish Hospitals)
      Dec 1, 2022

      r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

      Not yet recruiting
      • B-cell Lymphoma
      • Beijing, Beijing, China
        Deparment of Hematology, Peking University People's Hospital
      Aug 9, 2022

      Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Philadelphia Chromosome-Positive
      • Blinatumomab
      • +3 more
      • New York, New York
      • +1 more
      Nov 10, 2022

      Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

      Recruiting
      • Olverembatinib
      • +2 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Jul 26, 2022

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

      Recruiting
      • Acute Myeloid Leukemia, in Relapse
      • Acute Myeloid Leukemia Refractory
      • Boston, Massachusetts
      • +2 more
      Jan 18, 2023

      Metabolic Alternation and Clinicohematological Characteristic in

      Not yet recruiting
      • CML, Chronic Phase
      • Tyrosine kinase inhibitor
      • (no location specified)
      Nov 6, 2023

      Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • East Melbourne, Victoria, Australia
      • +7 more
      Jan 20, 2023

      Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

      Active, not recruiting
      • Neoplasm
      • Beijing, China
      • +5 more
      Jan 31, 2023

      Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

      Recruiting
      • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
      • Gilteritinib Exposure
      • Goyang-si, Gyeonggi-do, Korea, Republic of
      • +4 more
      Aug 18, 2022